RE:RE:News
Statistical significance not achieved since sample group now too small. However, evidence/data clearly demonstrates a more marked difference between CaPre arm and control arm. I suspect another Phase 3 trial may be required if after pooling T1 and T2 results the sample size still isn't large enough to satisfy statistical requirements. So the good - revised analysis shows drug efficacy is even better than original released results but the bad - sample size now not large enough.